Daniel Grossbaum is an associate in White & Case's New York office and a member of the Firm's Global Competition and Antitrust Group. Mr. Grossbaum's practice focuses on complex antitrust matters, commercial matters, and counselling, and regularly represents global companies on novel antitrust and intellectual property issues.
Mr. Grossbaum also maintains an active pro bono practice, with a particular focus on education-related matters.
Mr. Grossbaum graduated from New York University School of law cum laude in 2016, where he served as managing editor of the New York University Environmental Law Journal.
Substantial experience with "reverse payment," Walker Process fraud, and "product hopping" pharmaceutical litigation. Among this experience includes significant work with experts regarding liability and class certification issues, work on motions for summary judgment as well as oppositions to motions for class certification involving both indirect and direct purchaser proposed classes.
Primary drafter and counsel for multiple amici before the Supreme Court of the United States.
Representing Anthem, Inc. in its defense at trial and on appeal against claims brought by the US Department of Justice to block Anthem's US$54 billion acquisition of Cigna Corporation.
Counsel for US subsidiary of Asian shipping company in criminal grand jury investigation by Department of Justice Antitrust Division.
California's New Reverse Payment Law Departs from Supreme Court Standard in FTC v. Actavis (2019)
Impact of the CARES Act on the Medical Device Industry (2020)
Impact of the CARES Act on the Pharmaceutical and Medical Devices Industries (2020)
NYSBA, Empire State Counsel (2017)
New York Super Lawyers, Antitrust Litigation "Rising Star" (2020)